In vitro and in vivo immunomodulatory effects of Cobalt protoporphyrin administered in combination with immunosuppressive drugs

Transplant Immunology

Volumn 24, Issue 1, 2010, Pages 1-8

  Besenzon, Federica ^a   Dedja, Arben ^a   Vadori, Marta ^a   Bosio, Erika ^a   Seveso, Michela ^a   Tognato, Elena ^a   Polito, Luigino ^a   Calabrese, Fiorella ^a   Valente, Marialuisa ^a   Rigotti, Paolo ^a   Ancona, Ermanno ^a   Cozzi, Emanuele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apoptosis; Cobalt protoporphyrin; Proliferation; Rat cardiac transplantation

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID; PROTOPORPHYRIN COBALT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC GRAFT REJECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MACACA; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYCLOSPORINE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PROTOPORPHYRINS; RATS; RATS, INBRED LEW; T-LYMPHOCYTES;

EID: 78449248024     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.08.002     Document Type: Article

References (22)

1. Katori M., Anselmo D.M., Busuttil R.W., Kupiec-Weglinski J.W. A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system. Transpl Immunol 2002, 9(2-4):227.
2. Kato H., Amersi F., Buelow R., et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001, 1(2):121.
3. Blydt-Hansen T.D., Katori M., Lassman C., et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003, 14(3):745.
4. Hancock W.W., Buelow R., Sayegh M.H., Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998, 4(12):1392.
5. Woo J., Iyer S., Cornejo M.C., et al. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol 1998, 6(2):84.
6. Tullius S.G., Nieminen-Kelha M., Buelow R., et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002, 74(5):591.
7. Soares M.P., Lin Y., Anrather J., et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998, 4(9):1073.
8. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997, 94(20):10925.
9. Pae H.O., Oh G.S., Choi B.M., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004, 172(8):4744.
10. McDaid J., Yamashita K., Chora A., et al. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. Faseb J 2005, 19(3):458.
11. Araujo J.A., Meng L., Tward A.D., et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 2003, 171(3):1572.
12. Chauveau C., Remy S., Royer P.J., et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 2005, 106(5):1694.
13. Yamashita K., Ollinger R., McDaid J., et al. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. Faseb J 2006, 20(6):776.
14. Takahashi K., Reynolds M., Ogawa N., Longo D.L., Burdick J. Augmentation of T-cell apoptosis by immunosuppressive agents. Clin Transplant 2004, 18 Suppl 12:72.
15. Dhein J., Walczak H., Baumler C., Debatin K.M., Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995, 373(6513):438.
16. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969, 57(2):225.
17. Dedja A., Dall'Olmo L., Cadrobbi R., et al. Heterotopic cardiac xenotransplantation in rodents: report of a refined technique in a hamster-to-rat model. Microsurgery 2005, 25(3):227.
18. Nakamura M., Ogawa N., Shalabi A., Maley W.R., Longo D., Burdick J.F. Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil. Clin Transplant 2001, 15 Suppl 6:36.
19. Camara N.O., Soares M.P. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 2005, 38(4):426.
20. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008, 60(1):79.
21. Naujokat C., Daniel V., Bauer T.M., Sadeghi M., Opelz G. Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis. Biochem Biophys Res Commun 2003, 310(2):347.
22. Rezzani R., Rodella L., Bianchi R., Goodman A.I., Lianos E.A. Protective effects of heme-oxygenase expression in cyclosporine A-induced injury. Curr Neurovasc Res 2005, 2(2):157.